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channels in the plasma membrane, endoplasmic reticulum, calcium pumps, and mitochondria contribute to the generation, amplitude, and frequency of these Ca 2ϩ change. In particular, several members of the transient receptor potential (TRP) family of calcium-permeable channels have profound effects on the function of ECs. Because of its multifaceted role in the control of cell function, proliferation, and motility, TRP channels have been suggested as a potential molecular target for control of tumor neovascularization. Since plasma membrane Ca 2ϩ channels are easily and directly accessible via the bloodstream, they are potential targets for a number of pharmacological and antibody-targeted therapeutic strategies, with specificity being the main limitation. In this review we discuss recent advances in understanding the role of Ca 2ϩ channels, with specific reference to TRP channels, in tumor vascularization process. tumor vascularization; endothelial cells; calcium ions; transient receptor potential channels TUMOR VASCULARIZATION provides blood supply for tumor growth and metastasis. It is now widely accepted that, in addition to endothelial cells (ECs), which are the first mechanical and functional interface between blood and tissues, other cellular components are important in vessel formation, including pericytes, inflammatory cells, and other resident or circulating precursors. They contribute directly or indirectly to the regulation of multiple steps during which "activated" ECs proliferate, migrate, differentiate, and are stabilized into a new circulatory network (12, 25) .
Although neovascularization occurs in different physiological and pathological processes such as embryo development, wound healing, cancer, cardiac ischemia, and diabetes, the mechanisms underlying its genesis and regulation can differ, particularly in tumor progression. The most striking evidence supporting this comes from the vascular targeting treatment (VTT) designed to damage tumor vasculature and inhibit local angiogenesis. Despite promising results, emerging data indicate that responses to VTT are short lived and resistance develops in the majority of patients (17, 63) . The partial ineffectiveness of VTT may be due to several reasons. Indeed an increasing amount of novel experimental evidence obtained from in vitro and in vivo challenge the classical angiogenesis model forcing us to consider new scenarios to explain the process of tumor neovascularization (10, 20, 33, 62, 66) .
ECs were previously considered to be genetically stable compared with tumor cells and therefore an ideal therapeutic target in the development of anti-angiogenic treatments. However, their stability has been questioned by several studies showing that tumor-derived endothelial cells (TECs) as well as pericytes differ significantly from their normal counterparts at genetic and functional levels (10, 57, 67) . Even macroscopic morphological analysis demonstrates that tumor blood vessels are irregular and dilated. Morphologically distinct venules, arterioles, and capillaries are undistinguishable (16, 26) . From the functional point of view this organization leads to a leaky and hemorrhagic network (16) . TECs have been isolated and cultured from human carcinomas on the basis of membrane markers and exhibit altered genotype, phenotype, and function. They are often aneuploid, display chromosomal instability, and have distinct gene expression profiles that distinguishes them from normal ECs. In addition, TECs avoid senescence in vitro, a process typical of normal ECs, and instead display enhanced proliferation, motility, and the inherent ability to organize into capillary-like tube formation (8, 10, 28) .
That TEC characteristics are a result of their distinct origin is a subject of strong debate. It has been suggested that while TECs might have been derived from normal endothelium, further phenotypic changes could be induced by the tumor microenvironment; e.g., by transfer of genetic material via exosomes and/or microvesicles that are released from the tumor cells (42) . This hypothesis is in agreement with the general accepted idea that endothelium is a highly versatile system able to adapt to local tissue exigencies. Accordingly, it has been reported that normal ECs cultured in the presence of soluble tumor cell-derived factors undergo changes in the pattern of expression of specific proteins (32) .
The other school of thought proposes that the peculiarity of TECs could be due to their alternative origin, independent of local preexisting differentiated ECs. They may be the result of vasculogenic events via differentiation of bone marrowderived circulating stem cells, tissue-resident normal stem cells, or tumor stem cells (10, 12, 19) . It could involve a sort of "recapitulation" of embryonic development. As aforementioned, true "angiogenesis" occurs only in later phases of development, being preceded by "vasculogenesis," because of the ability of multipotent cells to differentiate into ECs (9, 10, 12) . These "stem cells" include different populations such as hemangioblasts, precursors of endothelial as well as hematopoietic cells, and mesangioblasts that differentiate into ECs and mesodermal derivatives (bone, muscle, and cartilage). The primitive vasculature created by vasculogenesis is then remodeled by angiogenesis.
A large amount of data strongly suggests that bone marrowderived hematopoietic stem cells (HSCs) and non-HSC (mesenchimal progenitors), together with pericytes and inflammatory cells (including tumor-associated macrophages, TAMs), could contribute to tumor vascularization. In particular, great interest has been focused on circulating endothelial progenitor cells (EPCs), a subpopulation of bone marrow-derived mononuclear cells also found in peripheral blood. They promote vessel formation in adult, and it was recently reported that they have the ability to incorporate into tumoral tissues (10) . However, the precise role and relevance of the different EC progenitors in tumor vascularization in vivo is still controversial (10, 12, 19) . They could directly take part in vessel formation or/and act indirectly in a paracrine manner by stimulating ECs or by remodeling the extracellular matrix. On the basis of these considerations, TECs represent a suitable model to investigate the role of proangiogenic factors and their related cell signaling compared with the widely used ECs obtained from normal tissues.
Ca 2ϩ Channels: Molecular Identities and Functional Role in Tumor Vascularization
The role of Ca 2ϩ signals and channels in the cardiovascular function and disease is well recognized and subject of a number of recent reviews (50, 54, 58, 72) . Here we will focus our attention primarily on the proangiogenic Ca 2ϩ channels that have been described thus far. Several studies have highlighted the importance of agonist-stimulated Ca 2ϩ signals in angiogenesis. Tyrosine kinase receptor-binding growth factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) stimulate intracellular Ca 2ϩ ([Ca 2ϩ ] i ) increase in ECs and trigger complex intracellular cascades. Ca i 2ϩ signals can be generated due to the release of Ca 2ϩ from intracellular stores, depletion of which leads to activation of plasma membrane Ca 2ϩ entry via the storeoperated Ca 2ϩ entry mechanism SOCE. An alternative route is store-independent, receptor-operated Ca 2ϩ entry (ROCE). The molecular nature of all the channels involved in these processes, especially in the latter instance, is not very well established, and several of these channel properties as well as the mechanism of their activation remains to be determined.
The discovery of transient receptor potential (TRP) superfamily of channels provided putative candidates for nonvoltage-gated Ca 2ϩ entry mechanisms, including SOCE, or those activated by mechanical stretch as well as intracellular messengers such as 1,4,5-trisphosphate (InsP3) or arachidonic acid (AA) (6, 54) . Several TRP channels have been identified in a variety of ECs, e.g., TRPC1, TRPC4, TRPC6, TRPM7, TRPV1, and TRPV4 (18, 41) . They appear to be heterogeneously expressed in different EC types and contribute to agonist-induced or mechanical stretch-induced Ca 2ϩ entry to different extents in these cells (18, 47) . VEGF-mediated Ca 2ϩ entry has been described in detail in human microvascular ECs (HMVECs). Tyrosine phosphorylation of VEGF Receptor 2 (VEGFR2) triggers recruitment and activation of phospholipase C␥ (PLC␥), InsP3, and diacylglycerol (DAG) generation, and activation of TRPC3/TRPC6 channels via storeindependent mechanism, which is not yet understood (14, 60) . TRPC6 has been shown to be a critical component of the channels mediating Ca 2ϩ entry in response to VEGF and 1-oleoyl-2-acetyl-sn-glycerol (OAG, a membrane-permeant DAG analogue) in HMVECs. Expression of a dominant-negative (inactive) mutant of the channel reduced cell proliferation as well as EC migration and sprouting in matrigel (29) . Using a similar approach, Ge and coworkers (27) proposed a critical role for TRPC6 in promoting cell proliferation as well as "capillary-like" structure formations in vitro induced by VEGF, but not bFGF, stimulation of HUVECs (see also Fig. 1 ).
Besides the role in EC proliferation, migration, and sprouting, TRPC channels and in particular TRPC6 have been also implicated in the VEGF-DAG-mediated Ca 2ϩ entry and consequent increase in vascular permeability (Fig. 1) . The increase in vascular permeability and [Ca 2ϩ ] i induced by VEGF are independent of calcium store release, as they are not affected by thapsigargin. They are mimicked by OAG and can be potentiated by TRPC6 agonist flufenamic acid (60) . On the other hand, Malik's laboratory provided evidence for a role of TRPC1 in the increase of endothelial permeability (46, 56) (Fig. 1) . VEGF has been suggested to activate these channels via Ca 2ϩ store depletion mechanism in HUVECs. In HMVECs anti-TRPC1 antibody blocked VEGF-induced SOCE and cell permeability, while VEGF-mediated Ca 2ϩ signals were significantly increased when TRPC1 was overexpressed. Because of its role in EC permeability and its ability to oligomerize with TRPC1, the authors speculated that also TRPC4 could eventually participate with TRPC1 in this process (39) . The apparent variability in the type of VEGF-activated Ca 2ϩ channels involved in regulation of EC permeability could be partially explained by tissue differences, especially between small capillaries and large vessels. For example, the spectrum of the TRPC channels expressed in HMVECs is substantially different from that in HUVECs. TRPC4 is expressed in HUVECs but not in HMVECs (29) . Furthermore, a proangiogenic role for TRPC1 has been described in vivo. Knockdown of zebrafish TRPC1 by morfolinos caused severe angiogenic defects in intersegmental vessel sprouting, presumably due to impaired filopodia extension EC migration. TRPC1 appears to be downstream to VEGF in controlling angiogenesis and necessary to extracellular-regulated kinase (ERK) phosphorylation (74) .
Recently, interesting data showed that in addition to the reported role for TRPC1 and TRPC6 in SOCE, Orai1, and Stim1 (composing the CRAC channels) are key players in VEGF-mediated SOCE (1, 43) . Both transient and sustained phase of VEGF-evoked Ca 2ϩ entry are significantly reduced by suppression of Orai1 or Stim1 expression in HUVECs (Fig. 1) . VEGF stimulation promotes Stim1 clustering, a critical event in activation of channels mediating SOCE such as Orai1 and TRPC1 (11, 43) . Finally, a significant role for Orai1 in the angiogenic process both in vitro and in vivo was also demonstrated (1, 43) . It is important to note that these data do not rule out the possible contribution of TRPC1 to SOCE in these cells, especially when the functional interactions between Orai1 and TRPC1, which have been recently described, are taken into consideration (15, 34) . It was reported that activation of TRPC1 by STIM1 that occurs in response to store depletion is dependent on Orai1. Ca 2ϩ entry via Orai1 triggers recruitment of TRPC1 to the membrane where it is gated by STIM1. The role of Orai1 and STIm1 will not be elaborated in this review. However, it should be noted that Orai1 and TRP channels can concertedly contribute to various functions of ECs and TECs. The relative roles of these channels in will have to be assessed within the context of a particular cell type and possibly specific cellular stimuli. The origin and culture of ECs can induce significant changes in the phenotype of the cells and thus is it critical to take this point into consideration.
Different studies have suggested that TRPV4 is likely to be a key player in tumor vascularization and in particular cell migration (Fig. 1) . It is widely known that TRPV4 is widely expressed in the vascular endothelium where it is proposed to acts as a mechanosensor. TRPV4 in ECs is activated in responses to changes in cell morphology that occur during cell swelling or in response to shear stress. Fluid shear stress regulates cell reorientation in a TRPV4-dependent manner, whereas in larger arteries the channel is a key player in shear stress-induced vasodilation (30, 69) . Endogenous compounds also regulate TRPV4 function.
AA, a 20-carbon fatty acid released by proangiogenic factors as well as its metabolites, which are important inflammatory messenger, mediate EC migration toward sites of inflammation (18) . Both shear stress and agonist activation of TRPV4 leads to enhancement of EC proliferation and triggers collateral growth after arterial occlusion (70) . A recent study reported by us demonstrated that expression of endogenous TRPV4 is significantly higher in tumor-derived EC (human breast carcinoma, BTEC) compared with "normal" ECs (HMVEC) (Fig. 1) . Furthermore, AA-activated TRPV4 is essential for BTEC migration. Loss of TRPV4 expression results in decreased Ca i 2ϩ responses to the TRPV4-specific agonist 4␣-phorbol 12,13-didecanoate (4␣PDD) and complete inhibition of AA-induced migration of BTEC. The mechanism by which AA regulates TRPV4 was also revealed. AA induces actin remodeling in BTECs, which triggers recruitment of TRPV4 in the plasma membrane of BTEC (23) . What is interesting is that TRPV4 and Ca 2ϩ increases is seen at the leading edge of the BTEC. This suggests that AA stimulates local Ca 2ϩ signaling, which drives migration of BTEC. It is important to stress that while this study used TECs to investigate the effect of proangiogenic factors, a large number of previously reported studies have been performed in vitro on different types of primary or immortalized macrovascular and microvascular EC lines from human or animal normal tissues. In fact, study of proangiogenic calcium signaling in TECs has been initiated only very recently (2, 21, 22, 49, 51) . Notably the functional relevance of AAinduced calcium entry could be restricted to tumor-derived ECs, since AA evokes a relatively small calcium entry in normal HMVECs compared that detected in BTECs and, even more importantly, AA is unable to promote cell motility in wound healing assay in vitro in ECs (21, 22) . This opens the intriguing opportunity for differential pharmacological treatments in normal and tumor-derived human ECs. A number of cellular stress factors, including hypoxia, nutrient deprivation, and reactive oxygen species, are important stimuli of angiogenic signaling (55) . TRPM2 has been recently identified to mediate H 2 O 2 -dependent increase in macrovascular pulmonary EC permeability. TRPM2 knockdown by small interfering RNA (siRNA), inhibition by anti-TRPM2 antibody or overexpression of the TRPM2 short isoform (that acts as dominant negative for TRPM2 long isoform) significantly reduced the H 2 O 2 /Ca 2ϩ -mediated increase in EC paracellular permeability (31) (Fig. 1) . Finally, although implicated primarily in Mg 2ϩ rather than Ca 2ϩ homeostasis, TRPM7 is involved in a number of vascular pathologies such as hypertension and dysfunction of endothelial and smooth muscle cells (73) . TRPM7 inhibits human umbilical vein EC (HUVEC) proliferation; transfection of cells with TRPM7-specific siRNA decreased both TRPM7 transcripts and TRPM7-like currents and significantly enhanced HUVEC proliferation rate (Fig. 1) . The effect is likely due to an increase in ERK phosphorylation following the siTRPM7 transfection (36) . It is worth noting that TRPM7 has the dual ability to act as a channel and as a kinase, allowing its involvement both in cellular Mg 2ϩ status and in intracellular signaling. As briefly described in the previous section of the review, EPCs could be an important component of tumor vascoularization, although their role is still debated (24, 59) . Interesting data have been recently published pointing to a role of SOCE in the control of proliferation in EPCs isolated from peripheral blood of human healthy volunteers (65) . Suppression of Orai1 expression or expression of dominant negative mutants of Orai1 abolish SOCE in EPCs as well as tubule formation in matrigel assays (43) . Finally, TRPC1 has also been suggested to contribute to regulation of cell proliferation and cell migration of EPCs isolated from rats bone marrow (40) . However, the endogenous stimuli responsible for SOCE activation in EPCs are still unknown.
Macromolecular Complexes and Their Role in Ca 2ϩ

Signaling of EC
The specificity of [Ca 2ϩ ] i signaling is mainly achieved by intracellular molecular complexes, which assemble at precise cellular locations. This localization controls compartmentalization of Ca 2ϩ signals in the cell allowing generation of specific and local signaling events. It is therefore interesting to consider the localization Ca 2ϩ channels in TECs and to determine the milieu in which they function as well as their regulatory and accessory components. Such information might provide insights into their role in tumor angiogenesis.
Protein translocation to the plasma membrane is an important means to regulate TRP channels. Hormones, growth factors, and agonists targeted for G ␣q -coupled receptors can stimulate the translocation of several TRP channels, including TRPC1, TRPC3-6, TRPV1, and TRPV4 to the plasma membrane (13, 44, 48, 71) . As discussed above, AA-induced actin remodeling is associated with TRPV4 trafficking to the plasma membrane of BTECs, resulting in more functional TRPV4 channels in the surface membrane, which promotes Ca 2ϩ entry and drives the migration of tumor-derived ECs (23) (Fig. 2) . Recently, Ma and co-workers (45) showed that TRPV4-TRPC1 heteromeric channel trafficking to the plasma membrane is enhanced by Ca 2ϩ store depletion in HUVECs, which results in augmentation of [Ca 2ϩ ] i influx in ECs in response to shear flow. Interestingly, both TRPC1 and TRPV4 subunits are requested for an efficient membrane translocation (45) . In HUVECs, the TRPC1-TRPV4 heteromultimer translocates in caveolar compartments, as indicated by the strong colocalization with caveolin-1 (45) (see Fig. 2 for a schematic representation). In addition, both TRPV4 and TRPC1 were also previously reported to be colocalized with caveolin-1 in the caveolar compartment of the plasma membrane in HUVECs and HMVECs, respectively. It is interesting to speculate that inter- Fig. 2 . Schematic representation of the main macromolecular complexes described to have a role in the vascularization process. A: TRPV4 channels colocalize with actin (1); arachidonic acid (AA)-mediated actin-remodeling promotes TRPV4 vesicle to traffic and insert in the membrane (2); as a consequence more functional channels allow Ca 2ϩ entry (3) important for tumor-derived endothelial cell (TEC) migration (4) . B: vasoactive agonists, acting via specific receptors, induce activation of Ca 2ϩ release from the intracellular stores (1, 2) , which in turn is sensed by Stim1 and promotes TRPV4-TRPC1 heterotetramers to traffic to the plasma membrane (3) where they localize in caveolin-1-enriched compartments promoting Ca 2ϩ entry (4) . C: mechanical shear stress applied through the b1 integrins-mediated cell-extracellular matrix adhesions (1) activates TRPV4; consequent Ca 2ϩ entry through these channels (2) in turn is required for downstream signaling events promoting more b1integrin activation (3) that drive the cell and cytoscheletal reorganization response necessary for cell reorientation (4) . See text for additional definitions of abbreviations.
actions between the caveolar proteins, such as caveolin 1, and TRP channels are required for regulating the Ca 2ϩ fluxes through the channels and/or regulating the assembly of the channel complexes in specifc cellular compartments (64, 68) .
Caveolae have been described to be involved in the generation of EC plasma membrane signaling microdomains. Caveolae serve as platforms that sense and transducer various stimuli, e.g., hemodynamic changes, into intracellular biochemical signals that regulate not only Ca 2ϩ signaling but determine critical stages of growth and angiogenesis both in vitro and in vivo (7) . Indeed, caveolae are enriched with regulatory molecules like InsP3 receptor, Ca 2ϩ -ATPase, heterotrimeric GTP binding protein, and some TRP channels (61) . Specifically, in ECs, caveolar compartments regulate Ca 2ϩ fluxes (both release from intracellular stores and entry) and Ca 2ϩ -mediated signal transduction (37, 38, 52) . Assembly of these components into complexes within the caveolar domains or associated with these domains partitions them into specialized cellular compartments. Such close association of the proteins provides a route for increasing the specificity and rates of interactions between them. Scaffolding of effector molecules in close vicinity to the complex allows sensing of local signals. Such spatial compartmentalization is key to a complex process such as migration of ECs.
Other important molecular players that have been extensively implicated in cancer and vascularization process are the integrins. Their interaction with channels and functional roles in pathophysiology have been described earlier and are also subject of a review by Arcangeli and colleagues (3, 5) . Integrins are involved in the Ca 2ϩ -mediated vascularization process. In particular, TRPV4 is functionally associated with ␤1-integrins, and stimulation of ␤1-integrin on EC plasma membrane by mechanical strain promotes TRPV4-mediated Ca 2ϩ entry, which in turn activates additional ␤1-integrins and subsequent downstream cytoskeletal rearrangement (69) (see also Fig. 2) .
Specificity of Proangiogenic Calcium Signaling in TumorDerived Endothelial Cells: Concluding Remarks
A number of approaches have been successfully employed to block vascularization in murine tumor models and several are currently in clinical trials. They are often based on the pharmacological use of blockers specifically targeted to endothelial proangiogenic signaling molecules. One of the best examples is bevacizumab (Avastatin), an anti-VEGF antibody and the first antiangiogenic agent approved by the United States Federal Drug Administration (for colon cancer) (25) . The main drawback of this strategy, however, is its poor selectivity being based on biochemical pathways substantially shared by normal and tumor-associated vasculature.
Because of its multifaceted role in the control of cell proliferation and motility, the Ca 2ϩ machinery is a potential molecular target for strategies against tumor neovascularization. Ca 2ϩ signals are involved at different critical phases in the regulation of the complex process of angiogenesis and tumor progression. Carboxyamidotriazole, a nonselective synthetic Ca 2ϩ influx blocker, has been successfully employed in antiangiogenic therapy, and it is currently under phase I-III clinical trials for the treatment of solid tumors (4, 35). As many cancer cells remodel the expression or activity of their Ca 2ϩ signaling toolkit, our group has recently suggested that deregulation of intracellular Ca 2ϩ toolkit might provide a suitable target to design novel anti-angiogenic therapies (21, 22) . On the other hand membrane channels, as cell surface expressed proteins, are easily and directly accessible via the bloodstream, facilitating a number of treatment strategies.
However, identifying specific patterns or "fingerprints" of calcium channels expression associated with tumor neovascularization is a great challenge for basic biology and biomedical sciences. Since Ca 2ϩ signaling encompasses all cell types, developing cell-specific, or even channel-specific, therapies is an extremely difficult problem. In addition, the majority of endothelial calcium channels have only been detected and investigated in cultured EC lines or in primary cultured cells in vitro, sparse data are available regarding in situ measurements in blood vessels. Another important point that needs to be considered is that expression of ion channels in ECs critically depends on the external conditions (culture passages, growth conditions, confluence) (53) . It is therefore not surprising that the extensive amount of data on channel physiology in ECs are sometimes variable and quite often controversial and questionable with regard to their physiological significance. A better approach in future studies will be to direct efforts to investigate the candidate channel(s) as well as their physiological function in vivo. In conclusion, although a challenge for the abovementioned reasons, Ca 2ϩ channels still represent an extremely useful, and important, molecular target for intervention of tumor vascularization. Discovery of such therapies and the means to suppress tumor vascularization will be a milestone in the quest for cancer therapies.
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the author(s).
